Guyasuta Investment Advisors Inc Novartis Ag Transaction History

Guyasuta Investment Advisors Inc

$1.49 Billion
Q2 2025

A detailed history of Guyasuta Investment Advisors Inc transactions in Novartis Ag stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 10,767 shares of NVS stock, worth $1.28 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

10,767

Previous 10,454 2.99%

Holding current value

$1.28 Million

Previous $1.17 Million 11.76%

% of portfolio

0.09%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	BUY	$101.96 - $121.01 $31,913 - $37,876	313 Added 2.99%	10,767 $1.3 Million
Q1 2025 Apr 22, 2025	SELL	$97.14 - $115.57 $9,714 - $11,557	-100 Reduced 0.95%	10,454 $1.17 Million
Q4 2024 Jan 30, 2025	SELL	$96.78 - $117.18 $9,774 - $11,835	-101 Reduced 0.95%	10,554 $1.03 Million
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $203,557 - $231,867	-1,918 Reduced 15.25%	10,655 $1.23 Million
Q2 2024 Jul 22, 2024	SELL	$92.57 - $107.37 $9,349 - $10,844	-101 Reduced 0.8%	12,573 $1.34 Million
Q4 2023 Feb 05, 2024	SELL	$92.27 - $101.54 $380,798 - $419,055	-4,127 Reduced 24.56%	12,674 $1.28 Million
Q3 2023 Oct 25, 2023	SELL	$94.73 - $105.13 $11 Million - $12.2 Million	-116,388 Reduced 87.39%	16,801 $1.71 Million
Q2 2023 Jul 17, 2023	SELL	$92.52 - $104.91 $406,162 - $460,554	-4,390 Reduced 3.19%	133,189 $13.4 Million
Q1 2023 Apr 28, 2023	BUY	$80.03 - $92.81 $30,811 - $35,731	385 Added 0.28%	137,579 $12.7 Million
Q4 2022 Jan 30, 2023	SELL	$75.55 - $92.52 $8,612 - $10,547	-114 Reduced 0.08%	137,194 $12.4 Million
Q3 2022 Oct 25, 2022	BUY	$74.61 - $87.26 $89,084 - $104,188	1,194 Added 0.88%	137,308 $10.4 Million
Q2 2022 Jul 21, 2022	SELL	$80.52 - $93.75 $23,914 - $27,843	-297 Reduced 0.22%	136,114 $11.5 Million
Q1 2022 May 03, 2022	SELL	$80.11 - $90.62 $126,173 - $142,726	-1,575 Reduced 1.14%	136,411 $12 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $102,892 - $113,775	-1,291 Reduced 0.93%	137,986 $12.1 Million
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $49,149 - $57,179	601 Added 0.43%	139,277 $11.4 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $24,890 - $27,491	-292 Reduced 0.21%	138,676 $12.7 Million
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $307,363 - $362,468	-3,681 Reduced 2.58%	138,968 $11.9 Million
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $104,223 - $126,064	1,335 Added 0.94%	142,649 $13.5 Million
Q3 2020 Oct 28, 2020	BUY	$82.14 - $91.0 $3,285 - $3,640	40 Added 0.03%	141,314 $12.3 Million
Q2 2020 Aug 06, 2020	BUY	$80.93 - $91.1 $538,103 - $605,723	6,649 Added 4.94%	141,274 $12.3 Million
Q1 2020 Apr 28, 2020	BUY	$70.67 - $99.01 $8.33 Million - $11.7 Million	117,938 Added 706.77%	134,625 $11.1 Million
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $3,795 - $4,291	-45 Reduced 0.27%	16,687 $1.58 Million
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $102,648 - $113,112	-1,200 Reduced 6.69%	16,732 $1.45 Million
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $75,475 - $92,892	-1,001 Reduced 5.29%	17,932 $1.64 Million
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $21,842 - $24,983	-290 Reduced 1.51%	18,933 $1.82 Million
Q4 2018 Feb 11, 2019	SELL	$73.66 - $82.02 $22,098 - $24,606	-300 Reduced 1.54%	19,223 $1.65 Million
Q3 2018 Nov 08, 2018	BUY	$66.94 - $77.43 $123,504 - $142,858	1,845 Added 10.44%	19,523 $1.68 Million
Q2 2018 Aug 07, 2018	SELL	$64.91 - $73.36 $35,700 - $40,348	-550 Reduced 3.02%	17,678 $1.34 Million
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $60,887 - $72,789	-865 Reduced 4.53%	18,228 $1.47 Million
Q4 2017 Feb 12, 2018	SELL	$72.33 - $77.64 $159,849 - $171,584	-2,210 Reduced 10.37%	19,093 $1.6 Million
Q2 2017 Aug 09, 2017	BUY	N/A	21,303	21,303 $1.78 Million

Others Institutions Holding NVS

# of Institutions

1,552

Shares Held

142M

Call Options Held

1.64M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $257B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.

Account

Guyasuta Investment Advisors Inc Novartis Ag Transaction History